289 related articles for article (PubMed ID: 31388096)
1. Circulating microbiota-derived metabolites: a "liquid biopsy?
Aragonès G; Colom-Pellicer M; Aguilar C; Guiu-Jurado E; Martínez S; Sabench F; Antonio Porras J; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Obes (Lond); 2020 Apr; 44(4):875-885. PubMed ID: 31388096
[TBL] [Abstract][Full Text] [Related]
2. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
3. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
[TBL] [Abstract][Full Text] [Related]
4. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
[TBL] [Abstract][Full Text] [Related]
5. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
[TBL] [Abstract][Full Text] [Related]
6. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
7. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
León-Mimila P; Villamil-Ramírez H; Li XS; Shih DM; Hui ST; Ocampo-Medina E; López-Contreras B; Morán-Ramos S; Olivares-Arevalo M; Grandini-Rosales P; Macías-Kauffer L; González-González I; Hernández-Pando R; Gómez-Pérez F; Campos-Pérez F; Aguilar-Salinas C; Larrieta-Carrasco E; Villarreal-Molina T; Wang Z; Lusis AJ; Hazen SL; Huertas-Vazquez A; Canizales-Quinteros S
Diabetes Metab; 2021 Mar; 47(2):101183. PubMed ID: 32791310
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.
Aguilar-Olivos NE; Carrillo-Córdova D; Oria-Hernández J; Sánchez-Valle V; Ponciano-Rodríguez G; Ramírez-Jaramillo M; Chablé-Montero F; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
Ann Hepatol; 2015; 14(4):487-93. PubMed ID: 26019035
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome and nonalcoholic fatty liver diseases.
Zhu L; Baker RD; Baker SS
Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
[TBL] [Abstract][Full Text] [Related]
11. Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects.
Vega-Badillo J; Gutiérrez-Vidal R; Hernández-Pérez HA; Villamil-Ramírez H; León-Mimila P; Sánchez-Muñoz F; Morán-Ramos S; Larrieta-Carrasco E; Fernández-Silva I; Méndez-Sánchez N; Tovar AR; Campos-Pérez F; Villarreal-Molina T; Hernández-Pando R; Aguilar-Salinas CA; Canizales-Quinteros S
Liver Int; 2016 Sep; 36(9):1383-91. PubMed ID: 26945479
[TBL] [Abstract][Full Text] [Related]
12. Low Circulating Levels of Neurotensin in Women with Nonalcoholic Fatty Liver Disease Associated with Severe Obesity.
Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Aguilar C; Villar B; Sirvent JJ; Del Castillo D; Richart C
Obesity (Silver Spring); 2018 Feb; 26(2):274-278. PubMed ID: 29276861
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
[TBL] [Abstract][Full Text] [Related]
14. Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD.
Nobili V; Alisi A; Mosca A; Della Corte C; Veraldi S; De Vito R; De Stefanis C; D'Oria V; Jahnel J; Zohrer E; Scorletti E; Byrne CD
Liver Int; 2018 Feb; 38(2):342-349. PubMed ID: 28746779
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.
Aragonès G; González-García S; Aguilar C; Richart C; Auguet T
Biomed Res Int; 2019; 2019():8507583. PubMed ID: 30719448
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
17. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
19. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Buffet C
Bull Acad Natl Med; 2014 Dec; 198(9):1641-52. PubMed ID: 27356366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
